Recent Discovery Could Lead to a 'Holy Grail' Flu Treatment

Researchers have found that the pandemic 2009 H1N1 vaccine can generate antibodies in vaccinated individuals not only against the H1N1 virus, but also against other influenza virus strains.

The new discovery, by Dr Rafi Ahmed and his team at Emory University, the University of Chicago, could lead to a "holy grail" flu treatment, wiping it out for good and saving millions of lives, the Daily Express reported.

Age and Influenza Risk Linked
Scientists have established a link between age and the risk of suffering from the flu.

Development of a "universal" influenza vaccine that protects against multiple viral subtypes has long been the goal of immunologists working to overcome the requirement for a new vaccine during each flu season and the need for a rapid response to potentially dangerous mutations.

"Our finding is a key step in the development of a vaccine that can produce high levels of antibodies that protect against multiple flu strains, including challenging mutations that have the potential for widespread illness and death," Dr Ahmed said.

The study has been published in the journal Proceedings of the National Academy of Sciences.

Rapid Technique to Detect Influenza Virus Infection Developed
A new diagnostic technique has succeeded in detecting influenza virus infection in only 40 minutes.

Source-ANI

Southampton Researchers Spot Vital Peptides Capable of Leading to a Global Vaccine for Influenza
Many peptides, found on the internal structures of influenza viruses that may direct to the progress of a global vaccine for influenza, giving immunity against all strains of the diseases, revealed.

Epidemic of 2009 H1N1 Vaccination Breeds Antibodies Against Multiple Flu Strains
Plague of 2009 H1N1 vaccine can produce antibodies in vaccinated individuals against the H1N1 virus, and in addition against other influenza virus strains including H5N1 and H3N2.